First UK patient given GSK’s experimental arthritis drug in COVID-19 trial

Patient in Manchester is the first to be treated in new COVID-19 OSCAR trial investigating use of an experimental arthritis drug, otilimab (a human monoclonal antibody that inhibits granulocyte-macrophage colony-stimulating factor) for severe lung disease related to coronavirus.

Source:

PharmaTimes